XT
BCYC

XTX Topco’s Bicycle Therapeutics BCYC Stock Holding History

XTX Topco’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$494K Buy
106,392
+58,718
+123% +$336K 0.01% 2064
2025
Q4 		$338K Buy
47,674
+36,026
+309% +$266K 0.01% 1963
2025
Q3 		$90.2K Buy
+11,648
New +$87.9K ﹤0.01% 2044
2024
Q3 		– Sell
-10,177
Closed -$206K – 2093
2024
Q2 		$206K Buy
+10,177
New +$230K 0.02% 1220

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

XTX Topco's BCYC Position: Q1 2026 in Review

XTX Topco increased its Bicycle Therapeutics (BCYC) stake by 123% in Q1 2026, buying an estimated $336K and bringing the position to 106,392 shares worth $494K. The position accounts for 0.01% of the portfolio, ranked #2064.

XTX Topco first reported a position in BCYC in Q2 2024 and has held it in 4 quarters since. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • XTX Topco held 106,392 shares of Bicycle Therapeutics worth $494K as of Q1 2026.
  • XTX Topco bought 58,718 Bicycle Therapeutics shares in Q1 2026, an estimated $336K.
  • Bicycle Therapeutics made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2064 holding.
  • XTX Topco first reported a position in Bicycle Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.